Key result
Timely personalized TKI therapy in elderly Ph+ ALL patients can achieve long-lived responses and good quality of life, potentially allowing for cessation of treatment.
Authors
Loading...
Key points are not available for this paper at this time.
Foà et al. (2026) studied this question. Timely personalized TKI therapy in elderly Ph+ ALL patients can achieve long-lived responses and good quality of life, potentially allowing for cessation of treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: